Skip to main content

Research publications repository

    • čeština
    • English
  • English 
    • čeština
    • English
  • Login
View Item 
  •   CU Research Publications Repository
  • Fakulty
  • 2. Faculty of Medicine
  • View Item
  • CU Research Publications Repository
  • Fakulty
  • 2. Faculty of Medicine
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Posttreatment positivity of BCR::ABL1 in acute lymphoblastic leukemia: Should we keep track?

letter to the editors
Custom Licence Icon
accepted version
  • no other version
Thumbnail
File can be accessed.Get publication
Author
Zuna, JanScopus Profile - 6603899718
Hovorková, LenkaScopus Profile - 56602807100
Krotká, Justina
Winkowska, LucieScopus Profile - 57209969024
Novak, Zbynek
Šrámková, LucieORCiD Profile - 0000-0002-1035-422XWoS Profile - D-2935-2017Scopus Profile - 36960850500
Starý, JanORCiD Profile - 0000-0002-6818-7743WoS Profile - AAB-9635-2020Scopus Profile - 55400994700
Trka, JanORCiD Profile - 0000-0002-9527-8608WoS Profile - Y-4820-2019Scopus Profile - 7004214671
Cazzaniga, Giovanni
Cario, Gunnar
Žaliová, MarkétaORCiD Profile - 0000-0002-1639-7124Scopus Profile - 16481612200

Show other authors

Publication date
2023
Published in
American Journal of Hematology
Volume / Issue
98 (10)
ISBN / ISSN
ISSN: 0361-8609
ISBN / ISSN
eISSN: 1096-8652
Metadata
Show full item record
Collections
  • 2. Faculty of Medicine

This publication has a published version with DOI 10.1002/ajh.27022

Abstract
We read with a great interest the paper focused on different minimal residual disease (MRD) approaches and its significance in Ph+ acute lymphoblastic leukemia (ALL) patients, authored by Short et al. from the MD Anderson Cancer Center. We would like to thank the authors for this important data, and offer a short comment from our pediatric experience.
Keywords
BCR::ABL1, acute lymphoblastic leukemia
Permanent link
https://hdl.handle.net/20.500.14178/2140
Show publication in other systems
WOS:001029819700001
SCOPUS:2-s2.0-85165292273
PUBMED:37449465
License

This is the peer reviewed version of the following article: [Zuna J, Hovorkova L, Zaliova M. Posttreatment positivity of BCR::ABL1 in acute lymphoblastic leukemia: Should we keep track? Am J Hematol. 2023 Oct;98(10):E269-E271. Jul 14. PMID: 37449465.], which has been published in final form at [https://doi.org/10.1002/ajh.27022]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. This article may not be enhanced, enriched or otherwise transformed into a derivative work, without express permission from Wiley or by statutory rights under applicable legislation. Copyright notices must not be removed, obscured or modified. The article must be linked to Wiley’s version of record on Wiley Online Library and any embedding, framing or otherwise making available the article or pages thereof by third parties from platforms, services and websites other than Wiley Online Library must be prohibited.

(complete license conditions)

xmlui.dri2xhtml.METS-1.0.item-publication-version-

DSpace software copyright © 2002-2016  DuraSpace
Contact Us | Send Feedback
Theme by 
Atmire NV
 

 

About Repository

About This RepositoryResearch outputs typologyRequired metadataDisclaimerCC Linceses

Browse

All of DSpaceCommunities & CollectionsWorkplacesBy Issue DateAuthorsTitlesSubjectsThis CollectionWorkplacesBy Issue DateAuthorsTitlesSubjects

DSpace software copyright © 2002-2016  DuraSpace
Contact Us | Send Feedback
Theme by 
Atmire NV